Emory Healthcare Taps Atropos Health as Real-World-Evidence Partner

What You Should Know:

–  Atropos Health, a pioneer in in translating clinical data into personalized real-world evidence (RWE) and insights, announced its selection by Emory Healthcare, an academic health system in Georgia, to generate evidence from real-world data (RWD) through a new decision-making tool for clinicians. 

–   The tool aims to improve patient outcomes and lower costs through medication solutions. 

Transforming Healthcare with Real-World Evidence: Atropos Health and Emory Collaboration

Atropos Health, the developer of GENEVA OS, is revolutionizing healthcare by delivering rapid, data-driven evidence through a robust network of real-world data. By partnering with healthcare and life sciences organizations, Atropos Health aims to close evidence gaps from bench to bedside, enhance patient outcomes with data-driven care, and expedite groundbreaking research in medicine.

Advancing Patient Care Through Data-Driven Insights

• Rapid Evidence Generation: Atropos Health enables real-time clinical decision-making through advanced analytics and observational studies.
• Emory Pilot Program: Emory is leveraging Atropos Health’s platform to access vast, previously untapped clinical data, enhancing medication formulary design and care protocols.
• Real-World Impact: The collaboration aims to directly improve patient care by informing evidence-based treatment strategies.

The Atropos Evidence™ Network & Green Button™

• Unparalleled Data Access: The Atropos Evidence™ Network includes over 300 million patient records, supporting research on both large national datasets and localized Emory data.
• Seamless Clinician Support: Emory clinicians can utilize the Green Button™ for immediate access to real-world evidence, using supervised evidence development or the AI-powered ChatRWD® for generating observational study results within minutes.

Industry Leadership & Innovation

• Achieving the Quadruple Aim: “Closing the evidence gap is key to achieving the quadruple aim in healthcare,” said Dr. Brigham Hyde, CEO and co-founder of Atropos Health. “Emory’s commitment to integrating evidence-based technology into care protocols and formulary design places them at the forefront of innovation.”
• Federated Installation of GENEVA OS™: Customers benefit from a federated installation of GENEVA OS™ within their internal cloud data environments, ensuring secure, scalable access to critical insights.
• Access to Alexandria™: GENEVA OS™ customers can explore Alexandria™, a vast repository of tens of thousands of studies, along with specialized content packages in pharmacy, value-based care, and care management. Existing studies in Alexandria can be reanalyzed using local data to generate novel insights and evidence.

By harnessing cutting-edge analytics and a vast real-world data network, Atropos Health and Emory are driving transformative changes in patient care, research, and healthcare decision-making.